// App-Quantinova.ai

: The effect of apabetalone on attenuated coronary atherosclerotic plaque: insights from the ASSURE trial

Researchers

Presenter

  • D.S. Shishikura

Principal Investigators

  • Y.K. Kataoka

  • S.H. Honda

  • K.T. Takata

  • S.K. Kim

  • J.A. Andrews

  • P.J.P. Psaltis

  • J.J. Johansson

  • N.W. Wong

  • S.J.N. Nicholls

Medical Centers

  • South Australian Health and Medical Research Institute, Adelaide, Australia

  • Resverlogix Corp., Calgary, Canada

Locations

  • Australia

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • RVX-208

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved